Firstly, clinical features of COVID-19 patients were compared under the quartile classification of baseline cystatin C levels (less than 0.90, 0.90 to 1.08, 1.08 to 1.36, and more than 1.36 mg/L, respectively). This evidence concerns the gene CST3 and COVID-19.